David H. Bollinger

Array ( [id] => 1595212 [patent_doc_number] => 06492173 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Antisense inhibition of cyclin D2 expression' [patent_app_type] => B1 [patent_app_number] => 09/920760 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26685 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492173.pdf [firstpage_image] =>[orig_patent_app_number] => 09920760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1397520 [patent_doc_number] => 06537811 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Antisense inhibition of SAP-1 expression' [patent_app_type] => B1 [patent_app_number] => 09/920759 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29950 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537811.pdf [firstpage_image] =>[orig_patent_app_number] => 09920759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6934733 [patent_doc_number] => 20010056077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-27 [patent_title] => 'Pharmaceutical composition for treatment of duchenne muscular dystrophy' [patent_app_type] => new [patent_app_number] => 09/917907 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7485 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20010056077.pdf [firstpage_image] =>[orig_patent_app_number] => 09917907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783497 [patent_doc_number] => 20030064945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors' [patent_app_type] => new [patent_app_number] => 09/916466 [patent_app_country] => US [patent_app_date] => 2001-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 30374 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064945.pdf [firstpage_image] =>[orig_patent_app_number] => 09916466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852018 [patent_doc_number] => 20030144221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Antisense modulation of BCL2-associated X protein expression' [patent_app_type] => new [patent_app_number] => 09/908147 [patent_app_country] => US [patent_app_date] => 2001-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28016 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144221.pdf [firstpage_image] =>[orig_patent_app_number] => 09908147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692215 [patent_doc_number] => 20030039647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Tetraspan protein and uses thereof' [patent_app_type] => new [patent_app_number] => 09/905674 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26896 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20030039647.pdf [firstpage_image] =>[orig_patent_app_number] => 09905674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792505 [patent_doc_number] => 20030087849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Antisense modulation of HKR1 expression' [patent_app_type] => new [patent_app_number] => 09/898556 [patent_app_country] => US [patent_app_date] => 2001-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24870 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087849.pdf [firstpage_image] =>[orig_patent_app_number] => 09898556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1096761 [patent_doc_number] => 06822087 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-23 [patent_title] => 'Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation' [patent_app_type] => B1 [patent_app_number] => 09/719737 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 39 [patent_no_of_words] => 11329 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/822/06822087.pdf [firstpage_image] =>[orig_patent_app_number] => 09719737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016846 [patent_doc_number] => 20020103120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Regulation of human phosphodiesterase-like enzyme' [patent_app_type] => new [patent_app_number] => 09/891216 [patent_app_country] => US [patent_app_date] => 2001-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 26095 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103120.pdf [firstpage_image] =>[orig_patent_app_number] => 09891216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750270 [patent_doc_number] => 20030044790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes' [patent_app_type] => new [patent_app_number] => 09/876249 [patent_app_country] => US [patent_app_date] => 2001-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 15618 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044790.pdf [firstpage_image] =>[orig_patent_app_number] => 09876249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923081 [patent_doc_number] => 20020115626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Method of detecting inflammatory lung disorders' [patent_app_type] => new [patent_app_number] => 09/865812 [patent_app_country] => US [patent_app_date] => 2001-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9796 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115626.pdf [firstpage_image] =>[orig_patent_app_number] => 09865812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7634886 [patent_doc_number] => 06656732 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-02 [patent_title] => 'Antisense inhibition of src-c expression' [patent_app_type] => B1 [patent_app_number] => 09/860473 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31276 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/656/06656732.pdf [firstpage_image] =>[orig_patent_app_number] => 09860473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6129414 [patent_doc_number] => 20020076712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Human RNase H and compositions and uses thereof' [patent_app_type] => new [patent_app_number] => 09/861205 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6026 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076712.pdf [firstpage_image] =>[orig_patent_app_number] => 09861205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6243089 [patent_doc_number] => 20020045590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Inhibition of interaction of PSD93 and PSD95 with nNOS and NMDA receptors' [patent_app_type] => new [patent_app_number] => 09/853895 [patent_app_country] => US [patent_app_date] => 2001-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12560 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045590.pdf [firstpage_image] =>[orig_patent_app_number] => 09853895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1108365 [patent_doc_number] => 06809194 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-26 [patent_title] => 'Akt3 inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/851670 [patent_app_country] => US [patent_app_date] => 2001-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11184 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/809/06809194.pdf [firstpage_image] =>[orig_patent_app_number] => 09851670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847421 [patent_doc_number] => 20030166588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Splice-region antisense composition and method' [patent_app_type] => new [patent_app_number] => 09/848868 [patent_app_country] => US [patent_app_date] => 2001-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14400 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166588.pdf [firstpage_image] =>[orig_patent_app_number] => 09848868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6813657 [patent_doc_number] => 20030073207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors' [patent_app_type] => new [patent_app_number] => 09/848754 [patent_app_country] => US [patent_app_date] => 2001-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 88442 [patent_no_of_claims] => 145 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073207.pdf [firstpage_image] =>[orig_patent_app_number] => 09848754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615915 [patent_doc_number] => 20020064783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'Inhibition of bone tumor formation using antisense cDNA therapy' [patent_app_type] => new [patent_app_number] => 09/836410 [patent_app_country] => US [patent_app_date] => 2001-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7900 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20020064783.pdf [firstpage_image] =>[orig_patent_app_number] => 09836410 [rel_patent_id] =>[rel_patent_doc_number] =>)